1. Home
  2. LFMDP vs BCTXZ Comparison

LFMDP vs BCTXZ Comparison

Compare LFMDP & BCTXZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LifeMD Inc.

LFMDP

LifeMD Inc.

N/A

Current Price

$23.28

Market Cap

0.0

Sector

Health Care

ML Signal

N/A

Logo BriaCell Therapeutics Corp. Warrant

BCTXZ

BriaCell Therapeutics Corp. Warrant

N/A

Current Price

$0.10

Market Cap

0.0

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
LFMDP
BCTXZ
Founded
N/A
N/A
Country
United States
Canada
Employees
384
4
Industry
Medical/Nursing Services
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
N/A
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
LFMDP
BCTXZ
Price
$23.28
$0.10
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
3.1K
217.2K
Earning Date
N/A
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$18.50
$0.06
52 Week High
$24.34
$0.59

Technical Indicators

Market Signals
Indicator
LFMDP
BCTXZ
Relative Strength Index (RSI) 44.45 65.49
Support Level $23.15 $0.06
Resistance Level $24.05 $0.11
Average True Range (ATR) 0.22 0.02
MACD -0.04 0.00
Stochastic Oscillator 34.58 77.53

Price Performance

Historical Comparison
LFMDP
BCTXZ

About LFMDP LifeMD Inc.

LifeMD Inc is a patient-centric, direct-to-patient healthcare company providing a high-quality, cost-effective, and convenient way for patients to access virtual medical care and pharmacy services. The Company's portfolio of brands within continuing operations is now managed as a single operating segment, Telehealth. Telehealth platform integrates core capabilities, includes: A nationwide pharmacy network, A wholly-owned commercial pharmacy, A fully integrated patient care center, A direct-to-patient marketing infrastructure for acquisition and retention, and AI-enabled clinical and operational technologies.

About BCTXZ BriaCell Therapeutics Corp. Warrant

BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.

Share on Social Networks: